Global Demineralized Bone Matrix and Demineralized Allograft Market Growth 2025-2031

The global Demineralized Bone Matrix and Demineralized Allograft market size is predicted to grow from US$ 629 million in 2025 to US$ 941 million in 2031; it is expected to grow at a CAGR of 7.0% from 2025 to 2031.

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

The demineralized bone matrix market is primarily driven by the increasing demand for bone graft substitutes in orthopedic and dental surgeries. Demineralized bone matrix (DBM) is derived from human or animal bones and contains growth factors and proteins that promote bone regeneration and healing. The rising prevalence of musculoskeletal disorders, trauma, and dental conditions fuels the adoption of DBM as an effective and biocompatible bone graft material. However, the market also faces challenges, including the need for standardized and high-quality DBM products to ensure consistent clinical outcomes. Variability in DBM processing methods and composition may impact its efficacy and safety. Moreover, strict regulatory requirements and ethical concerns related to the sourcing and processing of DBM can pose challenges for manufacturers in the market.

LP Information, Inc. (LPI) ' newest research report, the “Demineralized Bone Matrix and Demineralized Allograft Industry Forecast” looks at past sales and reviews total world Demineralized Bone Matrix and Demineralized Allograft sales in 2024, providing a comprehensive analysis by region and market sector of projected Demineralized Bone Matrix and Demineralized Allograft sales for 2025 through 2031. With Demineralized Bone Matrix and Demineralized Allograft sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Demineralized Bone Matrix and Demineralized Allograft industry.

This Insight Report provides a comprehensive analysis of the global Demineralized Bone Matrix and Demineralized Allograft landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Demineralized Bone Matrix and Demineralized Allograft portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Demineralized Bone Matrix and Demineralized Allograft market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Demineralized Bone Matrix and Demineralized Allograft and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Demineralized Bone Matrix and Demineralized Allograft.

This report presents a comprehensive overview, market shares, and growth opportunities of Demineralized Bone Matrix and Demineralized Allograft market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Gel

Putty

Putty with Chips

Others

Segmentation by Application:

Dental Surgery

Spine Surgery

Trauma Surgery

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Medtronic

J &J (DePuy Synthes)

SeaSpine

Xtant Medical

Zimmer Biomet

Stryker

Straumann

Wright Medical Group

Hans Biomed

Arthrex

Key Questions Addressed in this Report

What is the 10-year outlook for the global Demineralized Bone Matrix and Demineralized Allograft market?

What factors are driving Demineralized Bone Matrix and Demineralized Allograft market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Demineralized Bone Matrix and Demineralized Allograft market opportunities vary by end market size?

How does Demineralized Bone Matrix and Demineralized Allograft break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.